Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
HIV Clinical Trials|August 21, 2002
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCVMassimo Puoti, Barbara Zanini, Raffaele Bruno, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Antiviral Therapy|July 26, 2005
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapyCarlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
HIV Research & Clinical Practice|March 7, 2020
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal studyAnna Celotti, Franco Gargiulo, Eugenia Quiros-Roldan, et al.
Iscience|May 8, 2023
Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infectionsStefania Arsuffi, Emanuele Sansone, Emanuele Focà, et al.
Scientific Reports|August 2, 2025
Acceptability of long acting injectable antiretroviral therapy in people living with HIV at a large single centreStefania Arsuffi, Camilla Mazzi, Stefano Calza, et al.
Current HIV Research|February 22, 2008
Haemostatic activation in HIV infected patients treated with different antiretroviral regimensAngelo Pan, Sophie Testa, Eugenia Quiros Roldan, et al.
BMC Infectious Diseases|June 12, 2021
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIVEsther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Open Forum Infectious Diseases|May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA CohortAlessandra Vergori, Adriana Cervo, Ashley Roen, et al.
AIDS Research and Human Retroviruses|October 25, 2017
Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern ItalyIlaria Izzo, Eugenia Quiros-Roldan, Barbara Saccani, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
HIV Clinical Trials|August 21, 2002
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCVMassimo Puoti, Barbara Zanini, Raffaele Bruno, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Antiviral Therapy|July 26, 2005
Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapyCarlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
HIV Research & Clinical Practice|March 7, 2020
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal studyAnna Celotti, Franco Gargiulo, Eugenia Quiros-Roldan, et al.
Iscience|May 8, 2023
Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infectionsStefania Arsuffi, Emanuele Sansone, Emanuele Focà, et al.
Scientific Reports|August 2, 2025
Acceptability of long acting injectable antiretroviral therapy in people living with HIV at a large single centreStefania Arsuffi, Camilla Mazzi, Stefano Calza, et al.
Current HIV Research|February 22, 2008
Haemostatic activation in HIV infected patients treated with different antiretroviral regimensAngelo Pan, Sophie Testa, Eugenia Quiros Roldan, et al.
BMC Infectious Diseases|June 12, 2021
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIVEsther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Open Forum Infectious Diseases|May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA CohortAlessandra Vergori, Adriana Cervo, Ashley Roen, et al.
AIDS Research and Human Retroviruses|October 25, 2017
Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern ItalyIlaria Izzo, Eugenia Quiros-Roldan, Barbara Saccani, et al.
Pageof 21